AHR and breast carcinoma: A recent study suggests that aryl hydrocarbon receptor (Ahr) is blocked, and CYP1A1, 1A2, 1B1 expression is down-regulated when treated with HSP (1–20 μM) in MCF-7 breast cancer cells [58].